ETF overview
Roundhill considers weight loss medications, particularly GLP-1 agonists, to be among the most groundbreaking innovations currently reshaping the global pharmaceutical landscape. This conviction underpins the Roundhill GLP-1 & Weight Loss ETF (OZEM), which is distinguished as the world's inaugural ETF exclusively focused on the GLP-1 and broader weight management sector. Notably, OZEM employs an active management approach.
Fund facts
- Expense ratio
- 0.59%
- Fund assets
- 56.12M USD (all share classes)
- Issuer
- Roundhill Investments
- Inception date
- May 21, 2024
- Number of holdings
- 25
Breakdown
Holdings (25)
| Name | Ticker | Weight |
|---|---|---|
| Eli Lilly & Co | LLY | 14.49% |
| Novo Nordisk A/S | NVO | 11.94% |
| Pfizer Inc | PFE | 8.38% |
| CSPC Pharmaceutical Group Ltd | 1093.HK | 6.04% |
| Kailera Therapeutics Inc | KLRA | 5.35% |
| Chugai Pharmaceutical Co Ltd | 4519.T | 4.95% |
| Amgen Inc | AMGN | 4.71% |
| Viking Therapeutics Inc | VKTX | 4.44% |
| AstraZeneca PLC | AZN | 4.07% |
| Hanmi Pharm Co Ltd | 128940.KS | 3.68% |
| and 12 more | ||
Historical returns do not guarantee future returns. This is not investment advice.
Roundhill Investments - GLP-1 & Weight Loss ETF (OZEM)
- Expense ratio
- 0.59%
- Fund assets
- 56.12M USD (all share classes)
- Issuer
- Roundhill Investments
- Inception date
- May 21, 2024
- Number of holdings
- 25
| Name | Ticker | Weight |
|---|---|---|
| Eli Lilly & Co | LLY | 14.49% |
| Novo Nordisk A/S | NVO | 11.94% |
| Pfizer Inc | PFE | 8.38% |
| CSPC Pharmaceutical Group Ltd | 1093.HK | 6.04% |
| Kailera Therapeutics Inc | KLRA | 5.35% |
| Chugai Pharmaceutical Co Ltd | 4519.T | 4.95% |
| Amgen Inc | AMGN | 4.71% |
| Viking Therapeutics Inc | VKTX | 4.44% |
| AstraZeneca PLC | AZN | 4.07% |
| Hanmi Pharm Co Ltd | 128940.KS | 3.68% |
| and 12 more | ||
Roundhill considers weight loss medications, particularly GLP-1 agonists, to be among the most groundbreaking innovations currently reshaping the global pharmaceutical landscape. This conviction underpins the Roundhill GLP-1 & Weight Loss ETF (OZEM), which is distinguished as the world's inaugural ETF exclusively focused on the GLP-1 and broader weight management sector. Notably, OZEM employs an active management approach.
Unlock all ETF data
Sign up for FreeUnlock all ETF data
Sign up for Free